Related Experiment Video
Updated: Oct 10, 2025

06:03
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
1.5K
Diagnostic Value of CD4/CD8 in Scrub Typhus
Kangkang Hong1,2, Ziping Shu3, Laodong Li3
1Pulmonary and Critical Care Medicine Ward, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
The American Journal of Tropical Medicine and Hygiene
|December 13, 2021
Summary
The CD4/CD8 ratio can help diagnose scrub typhus, a condition often mistaken for other febrile illnesses. This study found specific CD4/CD8 ratio patterns in scrub typhus patients compared to other infections.
Area of Science:
- Infectious Diseases
- Immunology
- Clinical Diagnostics
Background:
- Scrub typhus is frequently misdiagnosed in febrile patients, leading to inappropriate antibiotic use and complications.
- Accurate and timely diagnosis is crucial for effective treatment of scrub typhus.
Purpose of the Study:
- To evaluate the diagnostic value of peripheral blood immune cell counts and other biomarkers for scrub typhus.
- To identify reliable indicators that can differentiate scrub typhus from other febrile illnesses.
Main Methods:
- A retrospective review of 52 scrub typhus patients and control groups (bloodstream infection, HIV, CCAP, SCAP).
- Comparison of CD4/CD8 counts, CD4/CD8 ratio, and other laboratory markers between groups.
- Receiver-operating characteristic (ROC) curve analysis to assess diagnostic accuracy.
Main Results:
- Scrub typhus patients showed significantly lower CD4 counts and CD4/CD8 ratios compared to bloodstream infection, CCAP, and SCAP groups.
- CD4 counts and CD4/CD8 ratios were higher in scrub typhus than in the HIV infection group.
- The CD4/CD8 ratio demonstrated high diagnostic accuracy (Area Under Curve > 0.93) in ROC analysis.
Conclusions:
- The CD4/CD8 ratio is a valuable ancillary biomarker for the diagnosis of scrub typhus.
- This finding can aid in distinguishing scrub typhus from other common febrile diseases, potentially reducing misdiagnosis and antibiotic abuse.

